Tape or needle? new study aims to settle shoulder pain debate
NCT ID NCT07190768
First seen Oct 31, 2025 · Last updated Jun 23, 2026 · Updated 35 times
Summary
This study compares two common therapies—kinesio taping and dry needling—for treating subacromial pain syndrome, a common cause of shoulder pain. 100 adults aged 18-65 with shoulder pain lasting over 6 weeks will be randomly assigned to one of four groups: taping only, needling only, both, or a control. The goal is to see which approach reduces pain and improves shoulder function best over 4 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SHOULDER PAIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Kinesio Taping and Dry Needling
What this could lead to
If successful, this could show which therapy—or combination—works best for easing shoulder pain and improving function.
What could go wrong
This is a small, early-stage trial with no blinding, so results may be biased or not apply to everyone. Both treatments are low-risk but may not work for all patients.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.